1. Home
  2. MSW vs MNOV Comparison

MSW vs MNOV Comparison

Compare MSW & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSW
  • MNOV
  • Stock Information
  • Founded
  • MSW 2012
  • MNOV 2000
  • Country
  • MSW Hong Kong
  • MNOV United States
  • Employees
  • MSW N/A
  • MNOV N/A
  • Industry
  • MSW
  • MNOV Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSW
  • MNOV Health Care
  • Exchange
  • MSW NYSE
  • MNOV Nasdaq
  • Market Cap
  • MSW N/A
  • MNOV 76.0M
  • IPO Year
  • MSW 2024
  • MNOV 2005
  • Fundamental
  • Price
  • MSW $3.59
  • MNOV $1.46
  • Analyst Decision
  • MSW
  • MNOV Strong Buy
  • Analyst Count
  • MSW 0
  • MNOV 1
  • Target Price
  • MSW N/A
  • MNOV $9.00
  • AVG Volume (30 Days)
  • MSW 64.5K
  • MNOV 12.4K
  • Earning Date
  • MSW 05-25-2025
  • MNOV 05-08-2025
  • Dividend Yield
  • MSW N/A
  • MNOV N/A
  • EPS Growth
  • MSW 18.78
  • MNOV N/A
  • EPS
  • MSW 0.20
  • MNOV N/A
  • Revenue
  • MSW $31,769,612.00
  • MNOV N/A
  • Revenue This Year
  • MSW N/A
  • MNOV N/A
  • Revenue Next Year
  • MSW N/A
  • MNOV N/A
  • P/E Ratio
  • MSW $17.66
  • MNOV N/A
  • Revenue Growth
  • MSW 30.91
  • MNOV N/A
  • 52 Week Low
  • MSW $2.12
  • MNOV $1.12
  • 52 Week High
  • MSW $10.58
  • MNOV $2.55
  • Technical
  • Relative Strength Index (RSI)
  • MSW N/A
  • MNOV 37.20
  • Support Level
  • MSW N/A
  • MNOV $1.44
  • Resistance Level
  • MSW N/A
  • MNOV $1.53
  • Average True Range (ATR)
  • MSW 0.00
  • MNOV 0.06
  • MACD
  • MSW 0.00
  • MNOV 0.01
  • Stochastic Oscillator
  • MSW 0.00
  • MNOV 14.29

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

Share on Social Networks: